Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma
A. P. Barbour, E. T. Walpole, G. T. Mai, L. Barnes, D. I. Watson, S. P. Ackland, V. Wills, J. Martin, M. Burge, C. S. Karapetis, J. Shannon, L. M. Nott, V. Gebski, M. Oostendorp, K. Wilson, J. Thomas, G. Lampe, J. R. Zalcberg, J. Simes, M. Smithers
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma'. Together they form a unique fingerprint.